Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Multicenter Study of the Effects on Quality of Life of Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer

NCT00540800 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.

NCT NCT00540800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00540800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Multicenter Study of the Effects on Quality of Life of Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer
Lead sponsor
National Cancer Institute, Naples
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2004
Completion date
December 31, 2009
Enrollment
139 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer